Literature DB >> 11159984

Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.

A R Satoskar1, M Bozza, M Rodriguez Sosa, G Lin, J R David.   

Abstract

To determine the role of endogenous migration-inhibitory factor (MIF) in the development of protective immunity against cutaneous leishmaniasis, we analyzed the course of cutaneous Leishmania major infection in MIF gene-deficient mice (MIF(-/-)) and wild-type (MIF(+/+)) mice. Following cutaneous L. major infection, MIF(-/-) mice were susceptible to disease and developed significantly larger lesions and greater parasite burdens than MIF(+/+) mice. Interestingly, antigen-stimulated lymph node cells from MIF(-/-) mice produced more interleukin-4 (IL-4) and gamma interferon (IFN-gamma) than those from MIF(+/+) mice, although the differences were statistically not significant. IFN-gamma-activated resting peritoneal macrophages from MIF(-/-) mice showed impaired macrophage leishmanicidal activity and produced significantly lower levels of nitric oxide and superoxide in vitro. The macrophages from MIF(-/-) mice, however, produced much more IL-6 than macrophages from wild-type mice. These findings demonstrate that endogenous MIF plays an important role in the development of protective immunity against L. major in vivo. Furthermore, they indicate that the susceptibility of MIF(-/-) mice to L. major infection is due to impaired macrophage leishmanicidal activity rather than dysregulation of Th1 and Th2 responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159984      PMCID: PMC97968          DOI: 10.1128/IAI.69.2.906-911.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  Macrophage migration inhibitory factor: cytokine, hormone, or enzyme?

Authors:  M D Swope; E Lolis
Journal:  Rev Physiol Biochem Pharmacol       Date:  1999       Impact factor: 5.545

2.  Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection.

Authors:  A R Satoskar; L M Stamm; X Zhang; A A Satoskar; M Okano; C Terhorst; J R David; B Wang
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

3.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

4.  Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice.

Authors:  A Mikulowska; C N Metz; R Bucala; R Holmdahl
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

5.  Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.

Authors:  S Jüttner; J Bernhagen; C N Metz; M Röllinghoff; R Bucala; A Gessner
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

6.  Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.

Authors:  L M Stamm; A Räisänen-Sokolowski; M Okano; M E Russell; J R David; A R Satoskar
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

7.  Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader.

Authors:  E Pick; D Mizel
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

8.  Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.

Authors:  M Bozza; A R Satoskar; G Lin; B Lu; A A Humbles; C Gerard; J R David
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

9.  The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.

Authors:  H Y Lan; M Bacher; N Yang; W Mu; D J Nikolic-Paterson; C Metz; A Meinhardt; R Bucala; R C Atkins
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

Review 10.  Leishmania species: models of intracellular parasitism.

Authors:  J Alexander; A R Satoskar; D G Russell
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

View more
  41 in total

1.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease.

Authors:  Aaron P Kithcart; Gina M Cox; Thais Sielecki; Abigail Short; James Pruitt; Tracey Papenfuss; Todd Shawler; Ingrid Gienapp; Abhay R Satoskar; Caroline C Whitacre
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

3.  Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Authors:  Gordon A Awandare; Yamo Ouma; Collins Ouma; Tom Were; Richard Otieno; Christopher C Keller; Gregory C Davenport; James B Hittner; John Vulule; Robert Ferrell; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

4.  Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction.

Authors:  James M Harper; J Erby Wilkinson; Richard A Miller
Journal:  FASEB J       Date:  2010-03-10       Impact factor: 5.191

5.  Macrophage migration inhibitory factor regulates innate γδ T-cell responses via IL-17 expression.

Authors:  Hee Kyung Kim; Alvaro Baeza Garcia; Edwin Siu; Pathricia Tilstam; Rita Das; Scott Roberts; Lin Leng; Richard Bucala
Journal:  FASEB J       Date:  2019-02-28       Impact factor: 5.191

6.  Quest for new biomarkers in atherosclerosis.

Authors:  Yoonsang Cho; Angel Baldán
Journal:  Mo Med       Date:  2013 Jul-Aug

7.  Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.

Authors:  Rituparna Das; Mi-Sun Koo; Bae Hoon Kim; Shevin T Jacob; Selvakumar Subbian; Jie Yao; Lin Leng; Rebecca Levy; Charles Murchison; William J Burman; Christopher C Moore; W Michael Scheld; John R David; Gilla Kaplan; John D MacMicking; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

8.  Structures of Leishmania major orthologues of macrophage migration inhibitory factor.

Authors:  Julia M Richardson; Lesley S Morrison; Nicholas D Bland; Sandra Bruce; Graham H Coombs; Jeremy C Mottram; Malcolm D Walkinshaw
Journal:  Biochem Biophys Res Commun       Date:  2009-01-31       Impact factor: 3.575

9.  Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.

Authors:  Henry W Murray
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

10.  MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages.

Authors:  Lidia Prieto-Lafuente; William F Gregory; Judith E Allen; Rick M Maizels
Journal:  J Leukoc Biol       Date:  2009-01-29       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.